A new study, published in the New England Journal of Medicine, examines whether removing lymph nodes is always necessary in ...

Ir-Vax is under clinical development by ImmunoRestoration and currently in Phase I for Triple-Negative Breast Cancer (TNBC).

Ruxolitinib phosphate is under clinical development by Incyte and currently in Phase III for Coronavirus Disease 2019 (COVID-19) Associated Cytokine Release Syndrome.

A breast cancer diagnosis is almost always followed by invasive biopsies, surgery, radiotherapy, chemotherapy and hormone treatments. But could all that be set to change?

Two-year cumulative rate of invasive ipsilateral breast cancer was 5.9 and 4.2% for guideline-concordant care, active monitoring HealthDay News — For patients with ductal carcinoma in situ (DCIS), ...

Hepatobiliary cancers include a spectrum of invasive carcinomas arising in the liver (hepatocellular carcinoma; HCC), gall bladder, and bile ducts (collectively called biliary tract cancers). The most ...

Each year, more than 56,500 women are diagnosed with ductal carcinoma in situ (DCIS), a non-invasive type of breast cancer commonly referred to as Stage 0 breast cancer. A woman with DCIS is ...

Casdozokitug is a novel IL-27 antagonistic antibody being evaluated in two ongoing clinical studies: a Phase 1/2 study in advanced solid tumors and a Phase 2 study in hepatocellular carcinoma.

Another in the Journal of the American Medical Association suggests a new approach to a type of breast cancer called ductal carcinoma in situ, or DCIS. Every year, about 50,000 women in the U.S. are ...

Patients with low-risk ductal carcinoma in situ who received active monitoring had similar rates of invasive cancer as well as quality of life, anxiety, and depression, compared with those who ...

In a propensity score-matched analysis, adjuvant therapy was significantly associated with a higher risk for all-cause and cancer-specific mortality and disease recurrence compared with ...

Another in the Journal of the American Medical Association suggests a new approach to a type of breast cancer called ductal carcinoma in situ, or DCIS. The research was discussed Thursday at the ...